screening of cervical cancer: barriers and facilitators

references 1. juckett g, hartman-adams h. human papillomavirus: clinical manifestations and prevention. american family physician. 2010; 82(10): 1209-14. 2. world health organization. human papillomavirus infection and cervical cancer, 2012. [http://www.who.int/gho/publications/world_health_statis tics/en_whs2012_full.pdf ] 3. forouzanfar mh, foreman kj, delossantos am, lozano r, lopez ad, murray cj, et al. breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. lancet. 2011; 378(9801): 1461-84. 4. acog committee on practice bulletins - gynecology. acog practice bulletin no. 109: cervical cytology screening. obstet gynecol. 2009; 114(6): 1409- 20. 5. jin xw, lipold l, mckenzie m, sikon a. cervical cancer screening: what's new and what's coming? cleve clin j med. 2013; 80(3): 153-60. 6. lee jw, berkowitz z, saraiya m. low-risk human papillomavirus testing and other non-recommended human papillomavirus testing practices among u.s. health care providers. obstet gynecol. 2011; 118: 4-13. 7. spence ar, goggin p, franco el. process of care failures in invasive cervical cancer: systematic review and meta-analysis. prev med. 2007; 45(2-3): 93-106. 8. şirin a, atan s, tascı e. protection from cancer and early diagnosis applications in izmir, turkey: a pilot study. cancer nurs.2006; 29(3): 207-13. 9. menard j, kobetz e, maldonado jc, barton b, blanco j, diem j. barriers to cervical cancer screening among haitian immigrant women in little haiti, miami. j cancer educ. 2010; 25(4): 602-8. 10. ugwu eo, obi sn, ezechukwu pc, okafor ii, ugwu ao. acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in enugu, southeast nigeria. niger j clinpract. 2013; 16(2): 249-52. 11. tracy jk, lydecker ad, ireland l. barriers to cervical cancer screening among lesbians. j womens health (larchmt). 2010; 19(2): 229-37. 12. akyuz a, guvenç g, yavan t, çetinturk a, kok g. evaluation of the pap smear test status of women and of the factors affecting this status. gulhane med j.2006; 48(1): 25-9. 13. racey cs, withrow dr, gesink d. self-collected hpv testing improves participation in cervical cancer screening: asystematic review and meta-analysis. can j public health. 2013; 104(2): e159-66. 14. hitt wc, low g, bird tm, ott r. telemedical cervical cancer screening to bridge medicaid service care gap for rural women. telemed j e health. 2013; 19(5): 403-8. 15. poliquin v, decker k, altman a, lotocki r. changes in cervical cancer screening behavior for women attending pap test week clinics. int j womens health. 2013; 5: 141- 8. 16. drolet m, boily mc, greenaway c, deeks sl, blanchette c, laprise jf, et al. socio-demographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papilloma virus vaccination. cancer epidemiol biomarkers prev. 2013; 22(4): 641-52. 17. downs ls jr, scarinci i, einstein mh, collins y, flowers l. overcoming the barriers to hpv vaccination in high-risk populations in the us. gynecoloncol. 2010; 117(3): 486-90. 18. marcus ac, kaplan cp, crane la, berek js, bernstein g, gunning je, et al. reducing loss-to-follow-up among women with abnormal pap smears. results from a randomized trial testing an intensive follow-up protocol and economic incentives. med care. 1998; 36(3): 397- 410.